STOCK TITAN
  1. Home
  2. BLCM

Bailie Communucations Stock Price, News & Analysis

BLCM OTC

Company Description

Bailie Communucations (OTC: BLCM) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

BLCM stock has declined 100.0% over the past year.

This page provides a comprehensive overview of BLCM stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Bailie Communucations (BLCM) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All
-50.14%

Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic Alternatives

clinical trial
-12.65%

Bellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers Symposium

clinical trial
+8.77%

CORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

+8.77%

Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

+13.21%

Bellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers Symposium

conferences clinical trial
-2.92%

Bellicum Announces Presentation by UNC at ASH 2022 on Potential Abrogation of iC9 CAR T-Cell Toxicities with Rimiducid

Bailie Communucations has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, conferences, earnings. View all BLCM news →

SEC Filings

View All

No SEC filings available for BLCM.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BLCM Company Profile & Sector Positioning

Bailie Communucations (BLCM) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.